Vylor Launches a New Era in Corn:

INDIANAPOLIS, September 1, 2026 – Ahead of its planned separation on October 1, 2026, Corteva, Inc. (NYSE: CTVA) today unveiled the corn pipeline for its advanced seed and advanced genetics spin-off, Vylor.  The multi-year innovation roadmap will strengthen Vylor’s corn market leadership across core geographies, expand farmer choice and flexibility, and deliver long-term, royalty-advantaged growth[1].

“Corn is already one of the most planted crops in the world and its importance will only continue to grow. Our pipeline changes the game through 2035 with the industry’s first-ever trait designed to improve yield and yield stability. In field trials across the Americas, corn with this trait took outstanding performance to a new level by delivering an incremental three bushels per acre on average, with gains of up to 10 bushels per acre¹,” said Sam Eathington, chief technology officer of the future Vylor.

Eathington continued, “Vylor’s impressive corn portfolio will be the direct result of the billions of dollars we have invested over the past decade to help farmers keep pace with growing, changing markets. We are building long-term, royalty-advantaged technology platforms that give Vylor more freedom to innovate, grows our licensing business and positions the company for sustained leadership.”

Vylor’s corn portfolio is expected to deliver more than $2 billion in incremental revenue by 2035, including licensing[2]. All told, Vylor is on track to launch seven new corn technology platforms through 2035, which together will be sold across 90% of Vylor’s corn business. 

In 2028, Vylor expects the corn innovation roadmap to launch in Latin America with Abranvo™ technology, a platform that provides effective fall army worm control with two new modes of action coupled with yield and yield stability and multiple modes of herbicide tolerance. This will be followed by the launch of Vylor’s next generation insect control with two additional, proprietary new modes of action, extending fall army worm control. 

In 2029 the roadmap will move to North America, where Vylor plans  to deliver its next generation above-ground insect control technology coupled with its proprietary yield and yield stability trait.

Vylor product launches will continue through the end of this decade, across multiple regions, with the transformative, gene edited, multi-disease resistant (MDR) corn technology – another industry first.  Vylor’s MDR combats four separate corn diseases: Northern Corn Leaf Blight, Grey Leafspot, Southern Rust and Anthracnose Stalk Rot.  Vylor will also launch reduced stature corn, built on its next generation technology platforms and deployed in segments where it can deliver the greatest value to farmers. 

In 2031, also in North America, Vylor expects to redefine below-ground insect control for corn by launching a new product that offers two new, non-Bt[3] modes of action for corn rootworm – including one that is plant-based, an industry first.

Taken together, Vylor will be able to offer farmers the industry’s most comprehensive corn portfolio of proprietary, innovative and effective products via multiple routes to market, including licensing. 

Overall, Vylor’s corn strategy is anchored by three elements:

1.      A focus on farmers and ability to invest in technology that consistently delivers value for them;

2.      The ability to leverage elite germplasm to expand brand strength and enable out-licensing; and

3.      Proprietary biotech and gene-editing technology platforms that support the company’s move from licensee to licensor.

Vylor’s market leadership in corn is built on more than 100 years of advanced genetics and breeding expertise and the industry’s leading germplasm. The roadmap unveiled today puts Vylor in a position of continued leadership globally in corn.

About Corteva

Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.™ ® ℠ Trademarks and service marks of Corteva Agriscience and its affiliated companies.

Cautionary and Forward-Looking Statements

Statement under the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995:  Corteva and its respective representatives may from time to time make written or oral statements that are “forward-looking” and provide other than historical information, including statements contained in this press release, in the company’s other filings with the Securities and Exchange Commission (“SEC”), and in presentations, reports or letters to its stockholders.

In some cases, the company identified these forward-looking statements by such words or phrases as “plans,” “outlook,” "will," “is designed to,” "is confident that," "expect," "expects," "should," "could," "may," "will continue to," "believe," "believes," "anticipates," "predicts," "forecasts," "estimates," "projects," "potential," "intends," or similar expressions identifying "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on the company’s current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the risk factors included in Part I, Item 1A of Corteva’s Annual Report on Form 10-K for the year ended December 31, 2025 (the "2025 Form 10-K"), the section captioned "Forward-Looking Information" in Part II of the 2025 Form 10-K, the “Risk Factors” and “Cautionary Statement Concerning Forward-Looking Statements” sections of the preliminary information statement filed as Exhibit 99.1 to Vylor Inc.’s (“Vylor”) Registration Statement on Form 10, as amended, and to similar risk factors and cautionary statements in all other reports and forms filed with the SEC.

We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.  Forward-looking statements are qualified in their entirety by the above cautionary statement. We specifically decline to undertake any obligation, and specifically disclaim any duty, to publicly update or revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events, except as may be required by law.

Examples of forward-looking statements include, but are not limited to, Corteva's intent to separate and its related expectations for Corteva and Vylor, including the anticipated timing, attributes, performance and financial and other benefits of these and any other products in Vylor’s pipeline. These forward-looking statements reflect management's current expectations and are not guarantees of future performance and are subject to a number of risks and uncertainties, many of which are difficult to predict and beyond Corteva’s control.

Media contact
Derek Burleson
479-651-0275
Derek.burleson@corteva.com

Investor contact
Kim Booth
302-485-3190
kimberly.a.booth@corteva.com

[1] All descriptions and/or statements related to product or technology launch are subject to completion of field testing and applicable regulatory reviews

[2] Excludes other advanced technology platforms, such as gene edited, multi-disease resistant (MDR) corn

[3] Bacillus thuringiensis, a naturally occurring bacterium